Squarepoint’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
Other funds holding IMCR
Squarepoint's IMCR Position: Q3 2026 in Review
Squarepoint sold out of Immunocore (IMCR) in Q3 2026, closing a stake of 11,746 shares — an estimated $373K sold.
Squarepoint first reported a position in IMCR in Q3 2022 and held it in 13 quarters. The position peaked at $2.5M in Q2 2024. 55 funds tracked by Wall St. Rank hold IMCR as of Q3 2026.
- Squarepoint reported no remaining Immunocore position as of Q3 2026 after selling out during the quarter.
- Squarepoint sold 11,746 Immunocore shares in Q3 2026, an estimated $373K.
- Squarepoint first reported a position in Immunocore in Q3 2022 and held it in 13 quarters.
- Squarepoint's Immunocore position peaked at $2.5M in Q2 2024.
- 55 funds tracked by Wall St. Rank held Immunocore as of Q3 2026.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.